Alkem Laboratories Ltd
BSE: 539523
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 2.3K-9.3% | 2.5K-2.0% | 2.5K+7.2% | 2.4K+16.0% | 2.0K-10.6% | 2.3K-20.4% | 2.9K |
| Other Income | 205.69+56.4% | 131.53+29.8% | 101.37-13.0% | 116.58+4.5% | 111.59-34.0% | 169.18+40.8% | 120.19 |
| Total Income | 2.5K-6.0% | 2.6K-0.8% | 2.6K+6.2% | 2.5K+15.4% | 2.2K-12.2% | 2.5K-17.9% | 3.0K |
| EXPENSES | |||||||
| Expenditure | 2.0K+6.9% | 1.9K+1.9% | 1.8K+1.1% | 1.8K-1.8% | 1.9K+8.1% | 1.7K-22.8% | 2.2K |
| Tax | 119.03+41.7% | 84.01+9.0% | 77.05+34.2% | 57.41-22.4% | 73.95+18.9% | 62.17-11.3% | 70.09 |
| PROFIT | |||||||
| PBT | 336.09-52.4% | 706.15-11.8% | 800.71+17.8% | 679.67+126.7% | 299.83-59.4% | 738.40-3.8% | 767.67 |
| Net Profit | 217.06-65.1% | 622.14-20.9% | 786.73+19.9% | 656.16+136.9% | 276.94-61.7% | 723.12+3.7% | 697.58 |
| KEY METRICS | |||||||
| OPM % | 9.95%-16.18pp | 26.13%-4.19pp | 30.32%+3.56pp | 26.76%+12.25pp | 14.51%-6.51pp | 21.02%+1.27pp | 19.75% |
| NPM % | 8.81%-14.91pp | 23.72%-6.04pp | 29.76%+3.39pp | 26.37%+13.53pp | 12.84%-14.69pp | 27.53%+4.22pp | 23.31% |
| EPS | 18.16-65.1% | 52.03-14.0% | 60.53+16.3% | 52.04+175.5% | 18.89-66.6% | 56.56-3.1% | 58.34 |
Corporate Events
Board MeetingALKEM
202628May
Board Meeting
To consider and approve the Standalone and Consolidated Audi…
BSE Filing ↗ Board MeetingALKEM
202413Nov
Board Meeting
Consider and approve the Standalone and Consolidated Unaudit…
BSE Filing ↗ Board MeetingALKEM
202429May
Board Meeting
Consider and approve Standalone and Consolidated Audited Fin…
BSE Filing ↗ Board MeetingALKEM
20237Nov
Board Meeting
Consider and approve the Standalone and Consolidated Unaudit…
BSE Filing ↗ Board MeetingALKEM
202310Aug
Board Meeting
Consider and approve the Standalone and Consolidated Unaudit…
BSE Filing ↗